E. A. González

19-Nor-1-alpha-25-dihydroxyvitamin D2 (Paricalcitol) safely and effectively reduces the levels of intact parathyroid hormone in patients on hemodialysis.

Kévin Martin, E. A. González, Mary Gellens et al. · Journal of the American Society of Nephrology · 1998 · 344 citations

Hemodialysis, Urology, Medicine +13

A long-term, multicenter study of the efficacy and safety of paricalcitol in end-stage renal disease.

Jill S. Lindberg, Kévin Martin, E. A. González et al. · PubMed · 2001 · 73 citations

Glomerulonephritis, Hemodialysis, Urology +15

Therapy of secondary hyperparathyroidism with 19-nor-1alpha,25- dihydroxyvitamin D2

KJ Martin, E. A. González, ME Gellens et al. · American Journal of Kidney Diseases · 1998 · 73 citations

Parathyroid Disease, Secondary Hyperparathyroidism, Parathyroid Gland +1

Effect of U-73,122, an inhibitor of phospholipase C, on actions of parathyroid hormone in opossum kidney cells

Kévin Martin, Charles L. McConkey, Ammini K. Jacob et al. · American Journal of Physiology-Renal Physiology · 1994 · 23 citations

Renal Inflammation, Parathyroid Gland, Opossum Kidney Cells +20

Parathyroid hormone increases the expression of receptors for epidermal growth factor in UMR 106-01 cells.

Matthew T. Drake, Joseph J. Baldassare, Charles L. McConkey et al. · Endocrinology · 1994 · 22 citations

Epidermal Growth Factor, Human Growth, Parathyroid Disease +24